Berkshire Biomedical Corporation — Form C (Regulation Crowdfunding)

Berkshire Biomedical Corporation of Dallas, TX filed a Form C (Regulation Crowdfunding) with the SEC on 2025-02-24. Target raise $20K, up to $1.5M. Offered through StartEngine Primary, LLC.

Offering

Issuer

Financials (as filed)

People (7)

NameRoleLocation
John TimberlakePresident and CEO, and Board MemberBridgewater, NJ
John TimberlakePresident & CEOBridgewater, NJ
John TimberlakePresident, CEO, CFO, and DirectorBridgewater, NJ
Susan OwenDirectorDALLAS, TX
Thomas M RouseBoard ChairDALLAS, TX
Thomas RouseChairman, DirectorDALLAS, TX
Thomas RouseChairman of the BoardDALLAS, TX

Reg CF filing history (5)

FiledFormTargetMax
2026-04-06C-TR
2026-03-31C-AR
2025-05-12C-U$20K$1.5M
2025-05-06C-AR

More